Chapter/Section Purchase

Leave This Empty:

Global Enterovirus Vaccine Market Insights, Forecast to 2028

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Enterovirus Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Enterovirus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Coxasckievirus A
1.2.3 Coxasckievirus B
1.2.4 Human Enterovirus 71
1.2.5 Others
1.3 Market by Application
1.3.1 Global Enterovirus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Enterovirus Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Enterovirus Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Enterovirus Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Enterovirus Vaccine Sales by Region
2.4.1 Global Enterovirus Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Enterovirus Vaccine by Region (2023-2028)
2.5 Global Enterovirus Vaccine Revenue by Region
2.5.1 Global Enterovirus Vaccine Revenue by Region (2017-2022)
2.5.2 Global Enterovirus Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Enterovirus Vaccine Sales by Manufacturers
3.1.1 Global Top Enterovirus Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Enterovirus Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Enterovirus Vaccine in 2021
3.2 Global Enterovirus Vaccine Revenue by Manufacturers
3.2.1 Global Enterovirus Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Enterovirus Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Enterovirus Vaccine Revenue in 2021
3.3 Global Enterovirus Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Enterovirus Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Enterovirus Vaccine Sales by Type
4.1.1 Global Enterovirus Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Enterovirus Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Enterovirus Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Enterovirus Vaccine Revenue by Type
4.2.1 Global Enterovirus Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Enterovirus Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Enterovirus Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Enterovirus Vaccine Price by Type
4.3.1 Global Enterovirus Vaccine Price by Type (2017-2022)
4.3.2 Global Enterovirus Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Enterovirus Vaccine Sales by Application
5.1.1 Global Enterovirus Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Enterovirus Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Enterovirus Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Enterovirus Vaccine Revenue by Application
5.2.1 Global Enterovirus Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Enterovirus Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Enterovirus Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Enterovirus Vaccine Price by Application
5.3.1 Global Enterovirus Vaccine Price by Application (2017-2022)
5.3.2 Global Enterovirus Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Enterovirus Vaccine Market Size by Type
6.1.1 North America Enterovirus Vaccine Sales by Type (2017-2028)
6.1.2 North America Enterovirus Vaccine Revenue by Type (2017-2028)
6.2 North America Enterovirus Vaccine Market Size by Application
6.2.1 North America Enterovirus Vaccine Sales by Application (2017-2028)
6.2.2 North America Enterovirus Vaccine Revenue by Application (2017-2028)
6.3 North America Enterovirus Vaccine Market Size by Country
6.3.1 North America Enterovirus Vaccine Sales by Country (2017-2028)
6.3.2 North America Enterovirus Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Enterovirus Vaccine Market Size by Type
7.1.1 Europe Enterovirus Vaccine Sales by Type (2017-2028)
7.1.2 Europe Enterovirus Vaccine Revenue by Type (2017-2028)
7.2 Europe Enterovirus Vaccine Market Size by Application
7.2.1 Europe Enterovirus Vaccine Sales by Application (2017-2028)
7.2.2 Europe Enterovirus Vaccine Revenue by Application (2017-2028)
7.3 Europe Enterovirus Vaccine Market Size by Country
7.3.1 Europe Enterovirus Vaccine Sales by Country (2017-2028)
7.3.2 Europe Enterovirus Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Enterovirus Vaccine Market Size by Type
8.1.1 Asia Pacific Enterovirus Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Enterovirus Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Enterovirus Vaccine Market Size by Application
8.2.1 Asia Pacific Enterovirus Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Enterovirus Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Enterovirus Vaccine Market Size by Region
8.3.1 Asia Pacific Enterovirus Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Enterovirus Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Enterovirus Vaccine Market Size by Type
9.1.1 Latin America Enterovirus Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Enterovirus Vaccine Revenue by Type (2017-2028)
9.2 Latin America Enterovirus Vaccine Market Size by Application
9.2.1 Latin America Enterovirus Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Enterovirus Vaccine Revenue by Application (2017-2028)
9.3 Latin America Enterovirus Vaccine Market Size by Country
9.3.1 Latin America Enterovirus Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Enterovirus Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Enterovirus Vaccine Market Size by Type
10.1.1 Middle East and Africa Enterovirus Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Enterovirus Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Enterovirus Vaccine Market Size by Application
10.2.1 Middle East and Africa Enterovirus Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Enterovirus Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Enterovirus Vaccine Market Size by Country
10.3.1 Middle East and Africa Enterovirus Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Enterovirus Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sinovac Biotech
11.1.1 Sinovac Biotech Corporation Information
11.1.2 Sinovac Biotech Overview
11.1.3 Sinovac Biotech Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sinovac Biotech Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sinovac Biotech Recent Developments
11.2 Medigen Vaccine Biologics
11.2.1 Medigen Vaccine Biologics Corporation Information
11.2.2 Medigen Vaccine Biologics Overview
11.2.3 Medigen Vaccine Biologics Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Medigen Vaccine Biologics Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Medigen Vaccine Biologics Recent Developments
11.3 Shenzhen Neptunus
11.3.1 Shenzhen Neptunus Corporation Information
11.3.2 Shenzhen Neptunus Overview
11.3.3 Shenzhen Neptunus Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Shenzhen Neptunus Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Shenzhen Neptunus Recent Developments
11.4 Sinopharm
11.4.1 Sinopharm Corporation Information
11.4.2 Sinopharm Overview
11.4.3 Sinopharm Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sinopharm Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sinopharm Recent Developments
11.5 Adimmune
11.5.1 Adimmune Corporation Information
11.5.2 Adimmune Overview
11.5.3 Adimmune Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Adimmune Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Adimmune Recent Developments
11.6 Intravacc
11.6.1 Intravacc Corporation Information
11.6.2 Intravacc Overview
11.6.3 Intravacc Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Intravacc Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Intravacc Recent Developments
11.7 Shanghai Zerun Biotechnology
11.7.1 Shanghai Zerun Biotechnology Corporation Information
11.7.2 Shanghai Zerun Biotechnology Overview
11.7.3 Shanghai Zerun Biotechnology Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Shanghai Zerun Biotechnology Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shanghai Zerun Biotechnology Recent Developments
11.8 Beijing Minhai Biotechnology
11.8.1 Beijing Minhai Biotechnology Corporation Information
11.8.2 Beijing Minhai Biotechnology Overview
11.8.3 Beijing Minhai Biotechnology Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Beijing Minhai Biotechnology Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Beijing Minhai Biotechnology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Enterovirus Vaccine Industry Chain Analysis
12.2 Enterovirus Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Enterovirus Vaccine Production Mode & Process
12.4 Enterovirus Vaccine Sales and Marketing
12.4.1 Enterovirus Vaccine Sales Channels
12.4.2 Enterovirus Vaccine Distributors
12.5 Enterovirus Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Enterovirus Vaccine Industry Trends
13.2 Enterovirus Vaccine Market Drivers
13.3 Enterovirus Vaccine Market Challenges
13.4 Enterovirus Vaccine Market Restraints
14 Key Findings in The Global Enterovirus Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer